Zurich Cantonal Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $959K | Buy |
26,379
+4,027
| +18% | +$146K | ﹤0.01% | 1245 |
|
|
2025
Q1 | $809K | Sell |
22,352
-522
| -2% | -$18.9K | ﹤0.01% | 1292 |
|
|
2024
Q4 | $962K | Buy |
22,874
+5,104
| +29% | +$215K | ﹤0.01% | 1199 |
|
|
2024
Q3 | $987K | Sell |
17,770
-7
| -0% | -$389 | ﹤0.01% | 1132 |
|
|
2024
Q2 | $731K | Buy |
17,777
+93
| +0.5% | +$3.82K | ﹤0.01% | 1238 |
|
|
2024
Q1 | $826K | Buy |
17,684
+1,537
| +10% | +$71.8K | ﹤0.01% | 1168 |
|
|
2023
Q4 | $772K | Buy |
16,147
+2,011
| +14% | +$96.2K | ﹤0.01% | 1213 |
|
|
2023
Q3 | $504K | Buy |
14,136
+2,292
| +19% | +$81.7K | ﹤0.01% | 1399 |
|
|
2023
Q2 | $546K | Buy |
11,844
+947
| +9% | +$43.7K | ﹤0.01% | 1296 |
|
|
2023
Q1 | $437K | Buy |
10,897
+918
| +9% | +$36.8K | ﹤0.01% | 1374 |
|
|
2022
Q4 | $462K | Buy |
9,979
+425
| +4% | +$19.7K | ﹤0.01% | 1296 |
|
|
2022
Q3 | $396K | Buy |
9,554
+1,097
| +13% | +$45.5K | ﹤0.01% | 1342 |
|
|
2022
Q2 | $505K | Sell |
8,457
-790
| -9% | -$47.2K | ﹤0.01% | 1222 |
|
|
2022
Q1 | $672K | Sell |
9,247
-984
| -10% | -$71.5K | ﹤0.01% | 1156 |
|
|
2021
Q4 | $860K | Buy |
10,231
+3,175
| +45% | +$267K | ﹤0.01% | 1082 |
|
|
2021
Q3 | $636K | Buy |
7,056
+14
| +0.2% | +$1.26K | ﹤0.01% | 1138 |
|
|
2021
Q2 | $671K | Sell |
7,042
-353
| -5% | -$33.6K | ﹤0.01% | 1056 |
|
|
2021
Q1 | $842K | Buy |
7,395
+440
| +6% | +$50.1K | 0.01% | 941 |
|
|
2020
Q4 | $963K | Buy |
6,955
+832
| +14% | +$115K | 0.01% | 970 |
|
|
2020
Q3 | $503K | Hold |
6,123
| – | – | ﹤0.01% | 1094 |
|
|
2020
Q2 | $479K | Buy |
6,123
+1,296
| +27% | +$101K | ﹤0.01% | 1026 |
|
|
2020
Q1 | $214K | Buy |
4,827
+1,502
| +45% | +$66.6K | ﹤0.01% | 1202 |
|
|
2019
Q4 | $142K | Hold |
3,325
| – | – | ﹤0.01% | 1515 |
|
|
2019
Q3 | $142K | Hold |
3,325
| – | – | ﹤0.01% | 1430 |
|
|
2019
Q2 | $211K | Buy |
3,325
+212
| +7% | +$13.5K | ﹤0.01% | 1208 |
|
|
2019
Q1 | $216K | Buy |
3,113
+242
| +8% | +$16.8K | ﹤0.01% | 1163 |
|
|
2018
Q4 | $125K | Hold |
2,871
| – | – | ﹤0.01% | 1468 |
|
|
2018
Q3 | $219K | Buy |
2,871
+483
| +20% | +$36.8K | ﹤0.01% | 1253 |
|
|
2018
Q2 | $184K | Hold |
2,388
| – | – | ﹤0.01% | 1283 |
|
|
2018
Q1 | $122K | Hold |
2,388
| – | – | ﹤0.01% | 1490 |
|
|
2017
Q4 | $111K | Buy |
2,388
+880
| +58% | +$40.9K | ﹤0.01% | 1511 |
|
|
2017
Q3 | $80K | Hold |
1,508
| – | – | ﹤0.01% | 1521 |
|
|
2017
Q2 | $94K | Sell |
1,508
-840
| -36% | -$52.4K | ﹤0.01% | 1402 |
|
|
2017
Q1 | $159K | Hold |
2,348
| – | – | ﹤0.01% | 1084 |
|
|
2016
Q4 | $165K | Buy |
2,348
+922
| +65% | +$64.8K | ﹤0.01% | 1042 |
|
|
2016
Q3 | $101K | Buy |
1,426
+600
| +73% | +$42.5K | ﹤0.01% | 1257 |
|
|
2016
Q2 | $40K | Hold |
826
| – | – | ﹤0.01% | 1609 |
|
|
2016
Q1 | $52K | Hold |
826
| – | – | ﹤0.01% | 1417 |
|
|
2015
Q4 | $93K | Buy |
826
+601
| +267% | +$67.7K | ﹤0.01% | 1161 |
|
|
2015
Q3 | $22K | Buy |
225
+125
| +125% | +$12.2K | ﹤0.01% | 1470 |
|
|
2015
Q2 | $10K | Hold |
100
| – | – | ﹤0.01% | 1391 |
|
|
2015
Q1 | $6K | Buy |
+100
| New | +$6K | ﹤0.01% | 1758 |
|